search
Back to results

Renal Nerves Stimulation Study (RNS)

Primary Purpose

Hypertension, Renal Denervation

Status
Completed
Phase
Phase 2
Locations
Netherlands
Study Type
Interventional
Intervention
Electrical mapping, nerve stimulation checked renal denervation procedure
Electrial mapping, nerve stimulation guided renal denervation procedure
Sponsored by
Diagram B.V.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The patient is willing and able to comply with the protocol and has provided written informed consent.
  • Age 18-80 years
  • The patient has hypertension and is accepted for renal denervation or combined pulmonary bein isolation and renal denervation
  • Glomerular filtration rate >45 mL/min
  • No history of renal artery stenosis

Exclusion Criteria:

  • Type 1 diabetes mellitus
  • Contraindication to chronic anticoagulation therapy or heparin.
  • Chronic oxygen use
  • Primary pulmonary hypertension
  • Woman currently pregnant or breastfeeding or not using reliable contraceptive measures during fertile age.
  • Known secondary cause of hypertension
  • Mental or physical inability to participate in the study.
  • Renal artery stenosis >50% of the arterial lumen, or renal artery lumen ≤3 mm.
  • Dual or triple ipsilateral renal artery ostia.

Sites / Locations

  • A. Elvan

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

RNS-checked RDN

RNS-guided RDN

Arm Description

20 patients with hypertension will be enrolled undergoing RNS-checked RDN

20 patients with hypertension will be enrolled undergoing RNS-guided RDN

Outcomes

Primary Outcome Measures

arterial blood pressure response
Main study parameter will be the arterial blood pressure response to RNS prior to renal denervation and absence of blood pressure rise in response to pacing in the renal artery after RDN.

Secondary Outcome Measures

blood pressure at 3 months
Blood pressure at 3 months after the intervention
blood pressure at 6 months
Blood pressure at 6 months after the intervention
blood pressure at 12 months
Blood pressure at 12 months after the intervention
change in blood pressure compared to measurement before the intervention
change in blood pressure compared to measurement before the intervention

Full Information

First Posted
July 7, 2015
Last Updated
May 4, 2020
Sponsor
Diagram B.V.
search

1. Study Identification

Unique Protocol Identification Number
NCT02496117
Brief Title
Renal Nerves Stimulation Study
Acronym
RNS
Official Title
Feasibility of Electrical Mapping and Stimulation of Renal Arteries in Patients Undergoing Renal Denervation
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
March 14, 2014 (Actual)
Primary Completion Date
July 4, 2019 (Actual)
Study Completion Date
July 4, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Diagram B.V.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Study design: Investigator initiated, single centre, feasibility study Main objectives are twofold: To investigate the feasibility of RNS in patients with therapy resistant hypertension, which is assessing the functional distribution of renal nerves using 3D imaging and differential pacing modalities. To investigate the blood pressure responses and cardiac excitable properties to RNS, and subsequently perform a RDN procedure, guided by 3D mapping by two different techniques e.g. RNS-checked RDN and RNS-guided RDN procedures. Study population: 40 patients (18 - 80 yr old)
Detailed Description
Background: Approximately 10-15% of adults with hypertension are considered to be treatment resistant because their hypertension is uncontrolled despite taking three or more drugs that includes a diuretic. Renal denervation (RDN) is a novel treatment option for therapy resistant hypertension and its rationale originates in denervating the renal sympathetic efferent and afferent coupling with the central autonomic nervous system. By denervating the renal arteries, general sympathetic tone is reduced. Currently, RDN is performed by placing in a spiral pattern 5-6 ablation lesions in each renal artery. 15-30% of the patients do not have any benefit from this procedure. The reason for this is unknown. Experimental data show that renal nerve stimulation (RNS) may serve as a functional endpoint to assess completeness of the RDN procedure. A RNS-guided RDN may prove to be superior to standard RDN (RNS-checked) in blood pressure control. Main objectives are twofold: To investigate the feasibility of RNS in patients with therapy resistant hypertension, which is assessing the functional distribution of renal nerves using 3D imaging and differential pacing modalities. To investigate the blood pressure responses and cardiac excitable properties to RNS, and subsequently perform a RDN procedure, guided by 3D mapping by two different techniques e.g. RNS-checked RDN and RNS-guided RDN procedures. Secondary objective: The secondary objective is to compare both techniques (RNS-checked vs. RNS-guided) in terms of efficacy and safety. Hypotheses: We hypothesize that identification and localization of the sympathetic nerve bundles using 3D navigation systems and selective pacing manoeuvres will allow a functional approach to denervate the kidneys and improve the success rate of this procedure in patients with hypertension. We hypothesize that the RNS-guided RDN procedure will show better blood pressure data during follow up, since the completeness has been assessed in contrast to the RNS-checked RDN procedure. Study design: Investigator initiated, single centre, prospective, feasibility study Study population: 40 patients (18 - 80 yr old) 20 patients treated with RNS-checked RDN 20 patients treated with RNS-guided RDN Intervention: Two different techniques will be used in this trial: RNS-checked RDN RNS-guided RDN Main study endpoints: Main study parameter will be the arterial blood pressure response to RNS prior to RDN and absence of blood pressure rise in response to pacing in the renal artery after RDN. Secondary study endpoints: Blood pressure at 3, 6, 12 months after the intervention, and change in blood pressure compared to measurement before the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Renal Denervation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
RNS checked RDN
Masking
None (Open Label)
Masking Description
RNS guided RDN
Allocation
Non-Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
RNS-checked RDN
Arm Type
Active Comparator
Arm Description
20 patients with hypertension will be enrolled undergoing RNS-checked RDN
Arm Title
RNS-guided RDN
Arm Type
Experimental
Arm Description
20 patients with hypertension will be enrolled undergoing RNS-guided RDN
Intervention Type
Procedure
Intervention Name(s)
Electrical mapping, nerve stimulation checked renal denervation procedure
Other Intervention Name(s)
RNS-checked RDN
Intervention Type
Procedure
Intervention Name(s)
Electrial mapping, nerve stimulation guided renal denervation procedure
Other Intervention Name(s)
RNS-guided RDN
Primary Outcome Measure Information:
Title
arterial blood pressure response
Description
Main study parameter will be the arterial blood pressure response to RNS prior to renal denervation and absence of blood pressure rise in response to pacing in the renal artery after RDN.
Time Frame
during procedure
Secondary Outcome Measure Information:
Title
blood pressure at 3 months
Description
Blood pressure at 3 months after the intervention
Time Frame
3 months after the intervention
Title
blood pressure at 6 months
Description
Blood pressure at 6 months after the intervention
Time Frame
6 months after the intervention
Title
blood pressure at 12 months
Description
Blood pressure at 12 months after the intervention
Time Frame
12 months after the intervention
Title
change in blood pressure compared to measurement before the intervention
Description
change in blood pressure compared to measurement before the intervention
Time Frame
intervention - up to 12 months after the intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The patient is willing and able to comply with the protocol and has provided written informed consent. Age 18-80 years The patient has hypertension and is accepted for renal denervation or combined pulmonary bein isolation and renal denervation Glomerular filtration rate >45 mL/min No history of renal artery stenosis Exclusion Criteria: Type 1 diabetes mellitus Contraindication to chronic anticoagulation therapy or heparin. Chronic oxygen use Primary pulmonary hypertension Woman currently pregnant or breastfeeding or not using reliable contraceptive measures during fertile age. Known secondary cause of hypertension Mental or physical inability to participate in the study. Renal artery stenosis >50% of the arterial lumen, or renal artery lumen ≤3 mm. Dual or triple ipsilateral renal artery ostia.
Facility Information:
Facility Name
A. Elvan
City
Zwolle
State/Province
Overijssel
ZIP/Postal Code
8025AB
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34647513
Citation
Hoogerwaard AF, Adiyaman A, de Jong MR, Smit JJ, Heeg JE, van Hasselt BAAM, Elvan A. Renal nerve stimulation: complete versus incomplete renal sympathetic denervation. Blood Press. 2021 Dec;30(6):376-385. doi: 10.1080/08037051.2021.1982376. Epub 2021 Oct 14.
Results Reference
derived

Learn more about this trial

Renal Nerves Stimulation Study

We'll reach out to this number within 24 hrs